A recombinant vaccinia-rabies virus in the immunocompromised host: oral innocuity, progressive parenteral infection, and therapeutics

By Hanlon C.A.   Niezgoda M.   Shankar V.   Hong S.N.   Koprowski H.   Rupprecht C.E.  

Vaccine, Vol. 15, Iss. 2, 1997-02 ,pp. : 140-148

Elsevier

Access to resources Recommend Favorite

Rabies vaccination: comparison of neutralizing antibody responses after priming and boosting with different combinations of DNA, inactivated virus, or recombinant vaccinia virus vaccines

By Lodmell D.L.   Ewalt L.C.  

Vaccine, Vol. 18, Iss. 22, 2000-05 ,pp. : 2394-2398

Elsevier

Access to resources Recommend Favorite

Kinetics of humoral immune response after rabies VR-G oral vaccination of captive fox cubs (Vulpes vulpes) with or without maternally derived antibodies against the vaccine

By Blasco E.   Lambot M.   Barrat J.   Cliquet F.   Brochier B.   Renders C.   Krafft N.   Bailly J.   Munier M.   Pastoret P.-P.   Aubert M.F.A.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4805-4815

Elsevier

Access to resources Recommend Favorite

Recombinant vaccinia virus (WR strain) may not be suitable for ex vivo stimulation

By Xin K.-Q.   Kumamoto Y.   Jounai N.   Kojima Y.   Hamajima K.   Okuda K.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 5-6

Elsevier

Access to resources Recommend Favorite

Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection

By Nishikawa Y.   Inoue N.   Xuan X.   Nagasawa H.   Igarashi I.   Fujisaki K.   Otsuka H.   Mikami T.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1381-1390

Elsevier

Access to resources Recommend Favorite